Home » Topics » BioWorld Science

BioWorld Science
RSS

MG7-CART therapy evaluated for the first time in a patient with metastatic colorectal cancer

May 9, 2018

Provention Bio partners with Intravacc to advance CVB vaccine PRV-101

May 9, 2018

EMA approves Lynparza tablets for the treatment of platinum-sensitive relapsed ovarian cancer

May 9, 2018

FDA clears Palladio to begin phase II study of lixivaptan in ADPKD

May 9, 2018

CymaBay Therapeutics initiates phase IIb trial of seladelparin NASH

May 9, 2018

Bristol-Myers Squibb presents novel nuclear receptor ROR-gamma inverse agonists

May 9, 2018

Merck & Co. patents lysine-specific demethylase 5B inhibitors

May 9, 2018

New RIP-1 inhibitors discovered at Roche, Genentech

May 9, 2018

Intravenous formulation of Akynzeo launched in the U.S.

May 9, 2018

Cellcentric divulges new KAT3 and/or CREB-binding protein inhibitors

May 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...